Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Infect Dis ; 218(6): 868-875, 2018 08 14.
Article in English | MEDLINE | ID: mdl-29733351

ABSTRACT

Background: Several studies have reported outbreaks due to human metapneumovirus (hMPV) in long-term care facilities (LTCF) for the elderly. However, most of these reports are epidemiological studies and do not investigate the clinical features of hMPV pneumonia. Methods: Three independent outbreaks of hMPV occurred at separate LTCF for intellectually challenged and elderly residents. A retrospective evaluation of hMPV pneumonia and its clinical and radiological features was conducted using available medical records and data. Results: In 105 hMPV infections, 49% of patients developed pneumonia. The median age of pneumonia cases was significantly higher than non-pneumonia cases (P < .001). Clinical manifestations of hMPV pneumonia included high fever, wheezing in 43%, and respiratory failure in 31% of patients. An elevated number of white blood cells as well as increased levels of C-reactive protein, creatine phosphokinase, and both aspartate and alanine transaminases was also observed among pneumonia cases. Evaluation of chest imaging revealed proximal bronchial wall thickenings radiating outward from the hilum in most patients. Conclusions: The aforementioned characteristics should be considered as representative of hMPV pneumonia. Patients presenting with these features should have laboratory testing performed for prompt diagnosis.


Subject(s)
Disease Outbreaks , Paramyxoviridae Infections/epidemiology , Pneumonia/epidemiology , Pneumonia/virology , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Immunocompetence , Japan/epidemiology , Long-Term Care , Male , Middle Aged , Paramyxoviridae Infections/virology , Retrospective Studies , Tomography, X-Ray Computed , Young Adult
2.
J Infect Chemother ; 20(5): 289-92, 2014 May.
Article in English | MEDLINE | ID: mdl-24679738

ABSTRACT

High mobility group box 1 (HMGB-1) protein is involved in acute lung injury due to various etiologies. We evaluated HMGB-1 levels in sera and bronchoalveolar fluids in patients with pneumonia caused by Legionella pneumophila. Levels of HMGB-1 in the sera of patients with L. pneumophila pneumonia (32 cases) and control subjects (24 cases) were determined. Serum HMGB-1 levels in Legionella pneumonia were similar to those of the control subjects. No significant correlation between HMGB-1 levels and other biomarkers and the outcome of cases was observed. In contrast, HMGB-1 levels, as well as interferon-γ, in bronchoalveolar (BA) fluids from severe L. pneumophila pneumonia (7 cases) were significantly higher than those in the sera of identical patients. HMGB-1 levels in BA fluids were relatively higher in pneumonia cases with ALI than those without ALI. Our findings suggest that intra-pulmonary HMGB-1 may be involved in the pathophysiology of pneumonia caused by L. pneumophila.


Subject(s)
HMGB1 Protein/physiology , Legionnaires' Disease/etiology , Aged , Bronchoalveolar Lavage Fluid/chemistry , Female , HMGB1 Protein/analysis , Hepatocyte Growth Factor/physiology , Humans , Interferon-gamma/physiology , Male , Middle Aged
3.
Jpn J Infect Dis ; 66(1): 32-5, 2013.
Article in English | MEDLINE | ID: mdl-23429082

ABSTRACT

With the increase in global transportation, imported malaria has become a significant public health concern in Japan. In the present study, we retrospectively analyzed all imported malaria cases in Okinawa Prefecture from 1988 to 2012. In that period, 23 patients with imported malaria were admitted to the University of the Ryukyus Hospital. Malaria types observed included Plasmodium falciparum (14 cases), P. vivax (7 cases), combined P. falciparum and P. ovale (1 case), and combined P. vivax and P. malariae (1 case). All cases were resolved by anti-malarial treatment. The clinical data from these patients highlights the importance of collecting patient travel history and ensuring an adequate supply of both diagnostic test and drug treatments in Okinawa.


Subject(s)
Antimalarials/therapeutic use , Malaria/epidemiology , Plasmodium/isolation & purification , Adolescent , Adult , Child , Coinfection , Female , Humans , Japan/epidemiology , Malaria/drug therapy , Malaria/parasitology , Male , Middle Aged , Plasmodium/classification , Plasmodium/drug effects , Plasmodium/genetics , Retrospective Studies , Travel , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL